GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference

Trending Topics in Gastroenterology

Explore current gastroenterology questions, clinical answers, and emerging research by topic.

31

Impaired VO₂ Recovery Highlights Frailty Physiology in Cirrhosis : Liver Transpl | May 2026

Introduction Frailty and reduced functional capacity are increasingly recognized as major prognostic determinants in patients with Cirrhosis awaiting Liver Transplantation. The Six-Minute Walk Test is widely used to...

32

Wilson Disease Remains a Single-Gene Disorder : JHEP Reports | May 2026

Introduction Wilson disease (WD) is an autosomal recessive copper metabolism disorder caused by pathogenic variants in the ATP7B gene. Although genetic confirmation is increasingly incorporated into diagnostic algorithms,...

33

Tacrolimus Shows Promise in Refractory Paediatric AIH : Frontline Gastroenterol | May 2026

Introduction Autoimmune hepatitis (AIH) in children is typically managed with corticosteroids and azathioprine, achieving remission in most patients. However, a subset of paediatric patients remain refractory to standard...

34

Delisting for Clinical Improvement Emerges as a Practical Marker of Cirrhosis Recompensation : Liver Transpl | April 2026

Introduction The concept of recompensated cirrhosis has gained increasing importance with the advent of effective disease-modifying therapies for chronic liver disease, including antiviral treatment and sustained alcohol abstinence....

35

Integrating Portal Hypertension and HCC into a Unified Stage-Based Cirrhosis Model : Nat Rev Gastroenterol Hepatol | May 2026

Introduction Cirrhosis and hepatocellular carcinoma (HCC) represent closely interconnected consequences of chronic liver disease, with portal hypertension serving as a central driver of hepatic decompensation and a major...

36

Semaglutide Reduces Heavy Drinking in Alcohol Use Disorder with Obesity | The Lancet

Introduction Alcohol use disorder (AUD) remains a major global health challenge with limited pharmacologic treatment options and persistently high relapse rates. Although behavioural therapies remain foundational, currently approved...

37

PPAR Agonists in PBC: Hepatology | April 2026

Introduction Primary biliary cholangitis is a chronic cholestatic liver disease that can progress to cirrhosis and liver failure if inadequately treated. While ursodeoxycholic acid remains the first-line therapy,...

38

Extrahepatic Abdominal Surgery in Cirrhosis: EASL Clinical Practice Guidelines

Surgery in patients with cirrhosis is no longer viewed as uniformly prohibited, but it remains high-risk and must be approached in a structured way. The two most important...

39

Psychomotor Speed and Frailty in Advanced Liver Disease: AJG | April 2026

Introduction Minimal hepatic encephalopathy (MHE) and physical frailty are highly prevalent yet often under-recognised complications in patients with advanced chronic liver disease (AdvCLD). While MHE reflects subtle neurocognitive...

40

Oral Health Matters in Cirrhosis: JHEP Reports/ March 2026

Introduction: Cirrhosis is increasingly recognised as a multisystem disease influenced by inflammation, microbiome alterations, and extrahepatic factors. Poor oral health, particularly periodontitis, contributes to systemic inflammation and bacterial...

Previous
134512
Next
GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer